From the desk of Jonas Bergquist, MD, PhD
Exploring new therapeutic avenues for ME/CFS
On behalf of my team at the ME/CFS Collaborative Research Center at Uppsala University, I am pleased to share that we have published an overview of treatment trials for patients in an intensive care unit (ICU) whose symptoms parallel those of people with ME/CFS. This study connects well to the earlier published paper on the hypothesis of mechanisms in the same journal.
This overview explores the potential relevance of these treatments for ME/CFS. There are significant parallels in the treatment trials for prolonged critical illness that could be relevant for ME/CFS; this is consistent with the hypothesis of an overlap in the mechanisms that prevent recovery in both conditions..
Specifically, these treatments generally target:
Results in these studies suggest that prolonged critical illness might share many common disease mechanisms with the development of ME/CFS.
We are honored to have our overview of treatment trials published in Frontiers of Medicine. Collaborative research projects should investigate in the lessons from treatment trials for prolonged critical illness to better understand and solve ME/CFS. We are now initiating specific studies on endocrine hormone dysregulation.
Please give today, and join our fight to find answers!
We rely on contributions large and small from donors who understand that life-changing treatments will only emerge if we invest in research like Dr. Bergquist’s.
We are profoundly grateful for your support. With you on our team, we all have a reason to be hopeful!
Donate your appreciated stock directly to OMFCA and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).
OMFCA sells your securities and uses the proceeds to support our mission. You also do not pay capital gains tax on the transfer when the stock is sold. Giving appreciated stock can be more beneficial than giving cash. The “cost” of your gift is often less than the deduction you gain by making it. In advance, thank you for making this generous gift.
Gifting of Stock Instructions
Brokerage/Investment Firm: TD Waterhouse
Name on the Account: Open Medicine Foundation Canada
Account Number: 20LRHLA
OMFCA Canadian Revenue Agency (CRA) charity registration #: 74926 5518 RR0001
OMF Canada Registered Address:
Open Medicine Foundation Canada
2987 Baynes Road, Victoria, BC V8N-1Y4
Phone Number: 416-848-0055
Please speak to your personal tax advisor and then call OMFCA at 650-242-8669 to notify us of your donation or with any questions.